MACIMORELIN ACETATE
| Brand name | MACRILEN |
|---|---|
| Active ingredient | MACIMORELIN ACETATE |
| Strength | EQ 60MG BASE/POUCH |
| Dosage form | FOR SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2017 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8192719*PED | April 2028 | — |
| 8192719 | October 2027 | use U-2220 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.